PAUL KRUGMAN, NEW YORK TIMES: Think about people on the right. They're simultaneously screaming, they're going to send all of the old people to death panels and it’s not going to save any money. That’s a contradictory point of view.
TAPPER: Death panels would save money, theoretically.
KRUGMAN: The advisory path has the ability to make more or less binding judgments on saying this particular expensive treatment actually doesn’t do any good medically and so we’re not going to pay for it. That is actually going to save quite a lot of money.
Let me see I understand this. There are no "death panels" under Obamacare. Under Obamacare, an advisory panel will decide whether or not someone can get an expensive treatment. Some expensive treatments will not be approved by this advisory panel and that will save a lot of money. I assume that by deciding some treatments are not cost effective and treatment should be denied that some people will be permitted to die earlier than they otherwise would. This panel of government bureaucrats will decide who lives and dies. It is impolite and it is inflammatory harsh rhetoric to call this advisory panel a "death panel." Did I get that right?